Cardiac pheochromocytomas detected by Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) scintigraphy

被引：25
作者：
Chen, Libo
Li, Fang
Zhuang, Hongming
Jing, Hongli
Du, Yanrong
Zeng, Zhengpei
机构：
[1] Chinese Acad Med Sci, Dept Nucl Med, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Dept Endocrinol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[3] Univ Penn, Sch Med, CHOP, Dept Radiol, Philadelphia, PA 19104 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2007年 / 32卷 / 03期
关键词：
pheochromocytoma; heart; Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC);
D O I：
10.1097/01.rlu.0000255027.70167.cf
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary pheochromocytomas of the heart are extremely rare tumors and difficult to diagnose. Iodine labeled metaiodobenzylguanidine (MIBG) is the first choice of the nuclear medicine modality in the evaluation of adrenal pheochromocytoma. However, the sensitivity of MIBG in the diagnosis of extraadrenal pheochromocytoma is less optimal. In this preliminary report, the efficacy of octreotide scintigraphy using Tc-99m labeled hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) in the evaluation of primary cardiac pheochromocytoma was assessed.
引用
收藏
页码：182 / 185
页数：4
相关论文
共 29 条
[1]  
Balon HR, 2001, J NUCL MED, V42, P1134
[2]   Fluorine-18 DOPA PET imaging of paraganglioma syndrome [J].
Brink, I ;
Schaefer, O ;
Waz, M ;
Neumann, HPH .
CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) :39-41
[3]  
de Herder W W, 2005, J Endocrinol Invest, V28, P132
[4]  
Decristoforo C, 2000, J NUCL MED, V41, P1114
[5]   99mTc-Demotate 1:: first data in tumour patients -: results of a pilot/phase I study [J].
Decristoforo, C ;
Maina, T ;
Nock, B ;
Gabriel, M ;
Cordopatis, P ;
Moncayo, R .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) :1211-1219
[6]   MIBG and FDG PET findings in a patient with malignant pheochromocytoma: A significant discrepancy [J].
Ezuddin, S ;
Fragkaki, C .
CLINICAL NUCLEAR MEDICINE, 2005, 30 (08) :579-581
[7]  
Ezziddin S, 2006, J NUCL MED, V47, P223
[8]  
Fitzgerald P J, 1995, Cardiovasc Surg, V3, P557, DOI 10.1016/0967-2109(95)94459-A
[9]  
Gabriel M, 2003, J NUCL MED, V44, P708
[10]  
Hubalewska-Dydejczyk A, 2005, NUCL MED REV, V8, P155
123